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The sialic acidof complexN-glycans canbebiochemically engineeredby substituting thephysiological
precursor N-acetylmannosamine with non-natural N-acylmannosamines. The Kv3.1 glycoprotein, a
neuronal voltage-gated potassium channel, contains sialic acid. Western blots of the Kv3.1 glycopro-
tein isolated from transfected B35 neuroblastoma cells incubatedwithN-acylmannosamines veriﬁed
sialylated N-glycans attached to the Kv3.1 glycoprotein. Outward ionic currents of Kv3.1 transfected
B35 cells treatedwithN-pentanoylmannosamineorN-propanoylmannosamine had slower activation
and inactivation rates than those of untreated cells. Therefore, the N-acyl side chain of sialic acid is
intimately connected with the activation and inactivation rates of this glycosylated potassium
channel.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Voltage-gated potassium channels (Kv) are critical determinants
in control and modulation of the action potential repolarization in
neurons, cardiac myocytes and skeletal muscle. Kv3.1 is a member
of the Kv3 subfamily and all members have two absolutely
conserved N-glycosylation sites within the S1–S2 extracytoplasmic
linker [1,2]. It was demonstrated that the Kv3.1 pore-forming
a-subunit heterologously expressed in a cultured neuronal-derived
cell model, B35 neuroblastoma cell, contains sialylated N-glycans
[3,4], similar to that throughout the central nervous system [5].
The lack of sialylated N-glycans attached to the Kv3.1 protein led
to decreases in activation, inactivation and deactivation kinetics
of the ionic currents expressed from Kv3.1 transfected B35 cells
[4]. Other potassium channels which lack glycan attachment, as
well as sialic acid residues, have also been shown to alter channel
gating [6–13]. Since modiﬁcations of Kv channel regulation and
expression can lead to changes in action potential repolarization
[14], the expression of different Kv glycoforms and aglycoforms
are important in modulation of electrical signaling, and thus have
substantial impact on the development and maintenance of an
organism.chemical Societies. Published by E
e).Sialic acids represent a family of about 50 amino sugars. They are
found at terminal positions of carbohydrate chains and the carbox-
ylate group at the 1-carbon position is typically ionized at physio-
logical pH [15]. This structural feature of sialic acid has been
ascribed to modifying Kv channel gating [8,11–13]. Another main
structural and functional feature of sialic acids is the N-acyl side
chain at the 5-carbon position. The size of the N-acyl side chain
can be altered in cell culture and in vivo by substituting the ﬁrst
direct precursor of sialic acid, N-acetylmannosamine (ManNAc),
with non-natural N-acylmannosamines [16,17]. Moreover, the en-
zymeswhich convertManNAc toN-acetylneuraminic acid (Neu5Ac)
are promiscuous and can therefore change non-natural N-acylman-
nosamines, N-pentanoylmannosamine (ManNPent) and N-propa-
noylmannosamine (ManNProp), to the respective non-natural
sialic acids, N-pentanoylneuraminic acid (Neu5Pent) and N-propa-
noylneuraminic acid (Neu5Prop), with the result that these non-
natural sialic acids partially replace the natural sialic acids of the
glycoconjugates [18,19].
The primary aim of this paper was to determine whether the
N-acyl side chain at the 5-carbon position of sialic acid could im-
pact the conducting properties of the Kv3.1 channel heterologously
expressed in neuronal-derived cells. Treatment of Kv3.1 transfec-
ted B35 cells with ManNPent or ManNProp led to decreases in
the activation and inactivation rates of the outward ionic currents
for the inactivating current type while the deactivation rates were
unchanged. Additionally, the whole cell current patterns of thelsevier B.V. All rights reserved.
Fig. 1. Western blots of the Kv3.1 protein heterologously expressed in B35 neuroblastoma cells treated with N-acylmannosamines. Transfected B35 cells were treated with
(+) and without () N-pentanoylmannosamine (ManPent) (A) or N-propanoylmannosamine (ManProp) (B). Kv3.1 glycoproteins were partially puriﬁed and then treated with
(+) and without () neuraminidase (Neu). Arrows and lines denote the type of N-glycan attached to the Kv3.1 protein. Numbers represent the Kaleidoscope markers (in kDa).
Similar migration patterns were observed on at least three separate Western blots.
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ted B35 cells with natural sialic acids.
2. Materials and methods
2.1. B35 neuroblastoma cells and N-acylmannosamines
Wild type Kv3.1 (pore-forming a-subunit) transfected B35
neuroblastoma cells were established and maintained as described
elsewhere [4]. Stable transfected cells were utilized for Western
blotting and patch clamp studies. To change the natural sialic acid
residues to non-natural sialic acid residues, Kv3.1 transfected cells
were treated with ManNPent (5 mM) or ManNProp (5 mM) for
48–144 h. Preparation and analysis of N-acyl-D-mannosamines
were performed as previously described [17].
2.2. Western blots of M2 immunoafﬁnity puriﬁed Kv3.1 glycoprotein
Kv3.1 glycoproteins were immunoafﬁnity puriﬁed from trans-
fected B35 cells [4]. Neuraminidase (0.83 U/ll) (New England
Biolabs) was used to remove sialic acid residues from glycoconju-
gates. The control was buffer substituted for the enzyme.
Untreated and treated M2 immunoafﬁnity puriﬁed samples of
Kv3.1 glycoproteins were immunoblotted as described in [4]. The
rabbit anti-Kv3.1 antibody (Alamone Labs) was used to identify
the Kv3.1 glycoprotein [3,4].
2.3. Whole cell recordings
Electrophysiological measurements were obtained from trans-
fected B35 cells using the whole cell conﬁguration of the patch
clamp technique as described elsewhere [1,4]. Brieﬂy, the external
bath solution had the following composition (in mM): 5 potassium
aspartate, 135 sodium aspartate, 1 MgCl2 hexahydrate, 10 Mes, 60
mannitol (pH 6.3) and 295–312 mOsm. The intracellular solution
contained (in mM): 140 potassium aspartate, 10 EGTA, 5 MgCl2
hexahydrate, 10 HEPES, 50 mannitol (pH 7.2) and 320–340 mOsm.
Whole cell recordings were conducted with untreated and treated
cells on similar days. Cell capacitance and series resistance were
compensated throughout the course of experiments. Kv3.1 currents
were sampled at 10 kHz and subsequently ﬁltered at 1 kHz. Whole
cell current recordings were accepted when membrane seal resis-
tance was P1 GX, maximum current amplitudes were P400 pA,
andminimal cell capacitance was displayed after compensation [4].
2.4. Data analysis
Digitized whole cell current recordings from B35 cells were ana-
lyzed using the CLAMPFIT 9.0 analysis program (Axon Instruments)[4]. Normalized conductance–voltage relationshipswere ﬁttedwith
a Boltzmann equation of the form: g = gmax/[1 + exp(V0.5  Vm)/q]
where q denotes the slope factor, Vm stands for the test potential,
V0.5 is the potential at which the conductance was half maximal, g
is the conductance and gmax is themaximal conductance.Whole cell
current recordingswere analyzed for rise times, activation time con-
stants, inactivating current rates, and deactivation time constants as
previously described [4]. Kodak 1D image analysis software was
used to acquireWesternblot images andAdobe Photoshopwasused
for preparation of ﬁgure. Whole cell current ﬁgures were generated
using Origin 7.5 (OriginLab). Data are presented as the mean ± S.E.
and n represents the number of cells tested. Student’s t-test was uti-
lized to evaluate the statistical comparisons. Statistical signiﬁcance
was considered at P < 0.05.
3. Results and discussion
3.1. Sialylated N-glycans of the Kv3.1 glycoprotein
Treatment of several cultured cell lines with ManNPent and
ManNProp results in production of Neu5Pent and Neu5Prop on
the cell surface [18]. Transfected B35 cells expressing Kv3.1 were
treated with ManNPent and ManNProp and then the Kv3.1 glyco-
proteins were analyzed by Western blots (Fig. 1). A predominant
slower migrating band and a faint faster migrating band were ob-
served for cells untreated and treated with N-acylmannosamines.
As previously shown, the upper band represents two sialylated
complex N-glycans of the Kv3.1 glycoprotein while the lower band
consists of two oligomannose N-glycans [4]. In all cases, the upper
bands were sensitive to neuraminidase treatment. A difference was
that when cells were treated with ManNPent or ManNProp the
upper band migrated slightly faster than that from untreated cells.
Based on the most plausible explanations of the Western blots and
previous studies [3,4,18], the oligosaccharides of the Kv3.1 glyco-
protein isolated from untreated cells are referred to as natural
sialylated N-glycans and those from treated cells as non-natural
sialylated N-glycans.
3.2. Treatment of Kv3.1 transfected B35 cells with non-natural
N-acylmannosamines leads to decreased activation kinetics of
ionic currents
It was demonstrated that B35 cells expressing the Kv3.1 protein
with zero or one occupied N-glycosylation sites had outward ionic
currents with slower activation rates compared to those of the
Kv3.1 glycoprotein with both sites occupied [4]. A similar activa-
tion protocol was employed to analyze the ionic currents of
Kv3.1 transfected B35 cells which generated Kv3.1 glycoprotein
with natural and non-natural sialylated N-glycans (Fig. 2). Both
Fig. 2. Ionic currents from B35 cells treated with N-acylmannosamines displayed slower activation kinetics than untreated B35 cells. Both inactivating (A) and non-
inactivating (B) current types were observed for transfected B35 cells untreated (control, top panels) and treated with ManNPent (middle panels) and ManNProp (bottom
panels) from the indicated voltage protocol. Time scales were expanded for inactivating current types to show differences in activation kinetics (A, right panel). Gray lines
denote currents at +20 and +40 mV. Conductance–voltage (g/gmax) curves of both inactivating (left panel) and non-inactivating (right panel) current types (C). Rise times of
inactivating (right panel) and non-inactivating (left panel) currents types (D). n represents number of cells. Asterisks denote signiﬁcant difference from control.
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were observed for Kv3.1 transfected B35 cells untreated (top pan-
els) and treated with ManNPent (middle panels) and ManNProp
(bottom panels). The inactivating current type presents saturation
of current amplitudes at more depolarized potentials while the
non-inactivating current type does not reach saturation [20]. Previ-
ously, it was observed that the non-inactivating currents usually
had transient current peaks at the initial phase of the sweeps for
the Kv3.1 glycoform while the aglycoform usually lacked the
transient peak [4]. Similar to the natural-occurring Kv3.1 glyco-
form, the non-natural-occurring Kv3.1 glycoforms expressed non-
inactivating currents with transient peaks.Conductance–voltage (G–V) relationships were ﬁtted with the
Boltzmann isotherm for inactivating (left panel) and non-inactivat-
ing (right panel) current types (Fig. 2C). Currents were observed
when the test potential was greater than30 mV. However, current
amplitudes reached saturation much more readily for inactivating
current type than non-inactivating current type. Boltzmann param-
eters of inactivating current and non-inactivating current types
were similar for Kv3.1 transfected cells untreated (test potential at
which g/gmax = 0.5(V0.5) was 10.3 ± 1.3 mV and 24.0 ± 0.8 mV and
the slope of the current voltage plot (dV) was 9.7 ± 0.7 mV and
21.9 ± 0.8 mV) and treated with ManNPent (V0.5 was 11.6 ± 1.3 mV
and 24.8 ± 0.5 mV and dV was 8.3 ± 0.6 mV and 23.0 ± 0.5 mV) and
Fig. 3. Ionic currents from B35 cells treated with N-acylmannosamines inactivated to a lesser extent than untreated B35 cells. Whole cell currents were elicited from the
shown voltage protocol (right panel) for transfected B35 cells untreated (control, right panel) and treated with ManNPent and ManNProp (A). The bar graph represents the
percent of current remaining at the end of the +40 mV pulse relative to the current at the beginning of the pulse (B). Gray lines denote currents at +40 mV.
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9.1 ± 0.7 mV and 21.4 ± 0.8 mV), respectively. These values were
similar to [4]. To illustrate differences in activation kinetics of the io-
nic currents, time scales were expanded for the inactivating current
type (Fig. 2A, rightpanel). The rise times (timeneeded for the current
to rise from 10% to 90% of its peak current at a test potential) were
slowest at the lowest test potential and fastest at the highest poten-
tial for all Kv3.1 glycoformswhich indicates the voltage dependence
of the ionic currents. Rise times were faster for the glycosylated
Kv3.1 channel with natural sialylated N-glycans than those with
non-natural sialylated N-glycans for the inactivating current types
(Fig. 2D, left panel). On the other hand, differences were not
observed for non-inactivating current types (Fig. 2D, right panel).
These results are further supported by the activation time constants
(single exponential ﬁts of current at a test potential) plotted against
voltage which revealed that the activation rates of the inactivating
current types of the Kv3.1 channel were faster for the natural glyco-
form than both of the non-natural glycoforms while those of the
non-inactivating current types were unchanged (not shown).
3.3. Inactivation kinetics of ionic currents were slowed for Kv3.1
transfected B35 cells treated with N-acylmannosamines
Inactivation kinetics of ionic currents of B35 cells expressing the
glycosylated Kv3.1 channels were faster than those from unglyco-
sylated or partially glycosylated Kv3.1 channels [4]. Whole cell
recordings showed that initially the currents rapidly increased
with time, and then steadily reduced as the duration of the pulse
(2 s) continued for Kv3.1 transfected B35 cells untreated (left
panel) and those treated with ManNPent (middle panel) and
ManNProp (right panel) (Fig. 3A). Further the decrease in current
amplitudes at the end of pulses relative to the maximum currentamplitudes was greater for untreated cells versus treated cells.
The percent of current remaining for the Kv3.1 glycoform with nat-
ural sialic acids was 50 ± 4% (n = 9) when the test potential was
+40 mV while those with Neu5Pent and Neu5Prop were 63 ± 4%
(n = 5) and 67 ± 2% (n = 8), respectively (Fig. 3B). Therefore, the
non-natural sialic acids inﬂuence inactivation rates of the outward
ionic currents produced by the Kv3.1 channel.
3.4. Deactivation kinetics of ionic currents were similar for Kv3.1
transfected B35 cells untreated or treated with N-acylmannosamines
N-Glycans attached to the Kv3.1 protein enhance deactivation
kinetics of the outward ionic currents [4]. To examine the deactiva-
tion rates (ﬁtting the current at a test potential with a single
exponential) of transfected B35 cells untreated and treated with
N-acylmannosamines, cells were clamped at +40 mV for 25 ms to
activate Kv3.1 channels, and then channels were deactivated by
clamping cells to less depolarized potentials (Fig. 4A). All Kv3.1
glycoforms displayed rapid deactivation rates for inactivating and
non-inactivating current types (Fig. 4B), unlike the aglycoform [4].
Herewe have shown for the ﬁrst time that outward ionic current
kinetics of the Kv3.1 channel depended on the size of the N-acyl
chain at the 5-carbon position of sialic acid residues of the Kv3.1
glycoprotein. The activation and inactivation rates of the inactivat-
ing current type were slowed when natural sialic acid residues of
theKv3.1 glycoproteinwere substitutedwith non-natural sialic acid
residues. This reduction in the activation rates was more similar to
the partially glycosylated Kv3.1 channel than the aglycoform [4].
Further shifts in the activation kinetics were not due to shifts in
the voltage midpoints of channel activation, and therefore support
the gating stabilizing theory in describing the gating mechanism
of the Kv3.1 channel [4,8,13,14]. Although size differences of the
Fig. 4. Deactivation rates of ionic currents from B35 cells treated with N-acylmannosamines were unaffected. The voltage protocol (right panel) was utilized to obtain
deactivation currents for Kv3.1 transfected B35 cells (left panel) (A). Gray line denotes current at 30 mV. A bar graph illustrating the deactivation time constant (30 mV) of
transfected B35 cells in the absence (control) and presence of ManNPent and ManNProp for inactivating and non-inactivating currents types (B).
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channel kinetics of the two glycoformswere similar. This lack of dif-
ferencemaybedue to a combinationof the lengthof theN-acyl chain
and the amount of non-natural sialic acid incorporated. For instance,
the amountofNeu5Pent incorporatedmaybe less than that ofNeu5-
Prop [18,19]. In earlier studies, the functional importance of the N-
acyl side chains was demonstrated when cells (e.g. lymphoma or
Vero cells) became less sensitive to the uptake of polyoma or inﬂu-
enza A viruses upon treatment with ManNProp or ManNPent
[17,19,21]. Taken together, these results have shown a new impor-
tant biological characteristic in that theN-acyl side chain of neuram-
inic acidmodulates the activation and inactivation rates of the ionic
currents of Kv3.1 expressed in transfected B35 cells. We speculate
that physiological changesmay result frommodiﬁcation of the elec-
trical signaling in neurons, cardiac myocytes and skeletal muscle
when changing the size of the N-acyl chain of sialic acid residues
of the Kv3.1 glycoprotein.
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